Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Indika Leelasena
Institution:
University of the Sunshine Coast
Observed institution:
University of the Sunshine Coast
ORCID:
0009-0004-7786-623X
Observed ORCID:
0009-0004-7786-623X
OpenAlex ID:
A5003783041
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial
2022
·
Raburn M Mallory
, Neil Formica
, et al.
·
The Lancet Infectious Diseases
·
97
PDF
Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults
2023
·
Eugene Athan
, James Baber
, et al.
·
Clinical Infectious Diseases
·
56
PDF
Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial
2023
·
S. Ben Baker
, Imogen Bermingham
, et al.
·
Vaccines
·
31
PDF
Safety, Tolerability, and Pharmacokinetics of IMU‐935, a Novel Inverse Agonist of Retinoic Acid Receptor–Related Orphan Nuclear Receptor γt: Results From a Double‐Blind, Placebo‐Controlled, First‐in‐Human Phase 1 Study
2023
·
Thomas M. Polasek
, Indika Leelasena
, et al.
·
Clinical Pharmacology in Drug Development
·
24
PDF
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial
2024
·
Chijioke Bennett
, Wayne Woo
, et al.
·
The Lancet Infectious Diseases
·
22
PDF
Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum
2023
·
Bridget E Barber
, Azrin N Abd-Rahman
, et al.
·
Clinical Infectious Diseases
·
21
PDF
Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with Plasmodium falciparum
2025
·
Rebecca Webster
, Damian A. Oyong
, et al.
·
Science Translational Medicine
·
14
Characterising the blood-stage antimalarial activity of pyronaridine in healthy volunteers experimentally infected with Plasmodium falciparum
2024
·
Bridget E. Barber
, Rebecca Webster
, et al.
·
International Journal of Antimicrobial Agents
·
10
The pyrrolidinamide antimalarial drug MMV367 rapidly clears blood-stage Plasmodium falciparum in healthy adults with experimental malaria
2026
·
Bridget E. Barber
, Robin Denhardt-Eriksson
, et al.
·
Science Translational Medicine
A study testing the safety and effects of FB-102 in healthy volunteers
2026
·
Alistair Mallard
, Indika Leelasena
·
http://isrctn.com/
Show more works
View as search
Works count:
10
Citation count:
275
H-index:
8
I10-index:
8
Year
Topic
Type